Patent details

LUC00056 Product Name: An isolated antibody or fragment thereof comprising light chain and heavy chain CDR sequences according to EP-B1-2076541 claim 1 (SEQ ID NOs: 224,225,226 and 146, 147, 148), wherein the antibody or fragment thereof binds human IL-17 receptor A; especially an antibody comprising the light and heavy chain variable region sequences according to EP-B1-2076541 claim 2 (SEQ ID NOs: 40 and 14), such as an IgG2 antibody comprising the light and heavy chain variable region sequences according to EP-B1-2076541 claim 2 (SEQ ID NOs: 40 and 14); and specifically brodalumab; and its derivates protected by EP-B1-2076541.

Basic Information

Publication number:
LUC00056
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP078671948
Legal Status:
Inactive
Application number:
LUC00056
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/16/1155/001-002
Marketing Authorization Type:
Marketing Authorization Date:
19/07/2017
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
15/12/2017
First Marketing Authorization date:
19/07/2017
Grant date:
21/02/2018
Activation date:
Publication date:
20/12/2017
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
19/07/2032
SPC Extension Expiration:
19/07/2032
Rejection date:
Withdrawal date:

Owner

From:
15/12/2017
 
 

Name:
Kirin-Amgen Inc.
Address:
One Amgen Center Drive, Thousand Oaks CA 91320-1799, United States (US)

Agent

Name:
DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
From:
15/12/2017
Address:
PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2018/02
Publication date:
15/01/2018
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2018/04
Publication date:
23/03/2018
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
01/11/2027
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
15/12/2017 Application Form 4
20/12/2017 Outgoing Correspondence 1
21/02/2018 Publication 1
20/12/2017 Publication 1
21/02/2018 Certificate 2
15/12/2017 General Document 38